首页> 外文期刊>Transactions of the Royal Society of Tropical Medicine and Hygiene >Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions.
【24h】

Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions.

机译:高危人乳头瘤病毒病毒载量与宫颈病变之间的剂量反应关系分析。

获取原文
获取原文并翻译 | 示例
           

摘要

The aims of this study were to explore the dose-response relationship between high-risk human papillomavirus (hrHPV) load and cervical lesions; the relationship between hrHPV viral load and the severity of cervical lesions; and the clinical application of the hybrid capture II (HC-II) system in the secondary prevention of cervical cancer. HrHPV viral load was detected by the HC-II system and cervical lesions were diagnosed from biopsied tissue. Curve estimation and Mantel trend analysis were used to explore the dose-response relationship between hrHPV viral load and cervical lesions. Spearman's rank correlation analysis and ordinal regression model were used for the analysis of hrHPV viral load and the severity of cervical lesions. Curve estimation showed good correlation between cervical lesion rates and hrHPV viral load (r=0.775, P=0.008); the rate of cervical lesions increased with hrHPV viral load (chi(trend)=8.000, P<0.001). Medium intensity rank correlation was found between hrHPV viral load grades and the severity of cervical lesions (r(s)=0.321, P<0.001); a correlation appeared between hrHPV viral load and the severity of cervical lesions (P<0.001). These results suggest a dose-response relationship between hrHPV viral load and the severity of cervical lesions. This dependence has important clinical applications and shows the potential value of the HC-II system in cervical cancer prevention.
机译:本研究的目的是探讨高危型人乳头瘤病毒(hrHPV)负荷与宫颈病变之间的剂量反应关系。 hrHPV病毒载量与宫颈病变严重程度之间的关系;混合捕获II(HC-II)系统在宫颈癌的二级预防中的临床应用。 HC-II系统检测到HrHPV病毒载量,并从活检组织中诊断出宫颈病变。曲线估计和Mantel趋势分析被用于探索hrHPV病毒载量与宫颈病变之间的剂量反应关系。用Spearman秩相关分析和序数回归模型分析hrHPV病毒载量和宫颈病变的严重程度。曲线估计显示宫颈病变率与hrHPV病毒载量之间具有良好的相关性(r = 0.775,P = 0.008); hrHPV病毒载量使宫颈病变的发生率增加(chi(趋势)= 8.000,P <0.001)。 hrHPV病毒载量等级与宫颈病变严重程度之间存在中等强度等级相关性(r(s)= 0.321,P <0.001); hrHPV病毒载量与宫颈病变的严重程度之间存在相关性(P <0.001)。这些结果表明hrHPV病毒载量和宫颈病变的严重程度之间的剂量反应关系。这种依赖性具有重要的临床应用,并显示出HC-II系统在宫颈癌预防中的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号